BP1123

Rizatriptan benzoate

British Pharmacopoeia (BP) Reference Standard

• Synonim(y): Rizatriptan benzoate salt, MK-462, N,N-Dimethyl-2-[5-(1,2,4-triazol-1-ylmethyl)-1H-indol-3-yl]ethylamine benzoate salt
• Wzór empiryczny (zapis Hilla): C₁₅H₁₉N₅ · C₇H₆O₂
• Numer CAS: 145202-66-0
• Masa cząsteczkowa: 391.47
• Numer MDL: MFCD00866224
• Kod UNSPSC: 41116107
• NACRES: NA.24

Właściwości

• klasa czystości: pharmaceutical primary standard
• rodzina API: rizatriptan
• Formularz: crystalline
• okres trwałości: limited shelf life, expiry date on the label
• producent / nazwa handlowa: BP
• Zastosowanie: pharmaceutical; pharmaceutical small molecule
• Format: neat
• temp. przechowywania: 2-8°C
• ciąg SMILES: OC(=O)c1ccccc1.CN(C)CCc2c[nH]c3ccc(Cn4cncn4)cc23
• InChI: 1S/C15H19N5.C7H6O2/c1-19(2)6-5-13-8-17-15-4-3-12(7-14(13)15)9-20-11-16-10-18-20;8-7(9)6-4-2-1-3-5-6/h3-4,7-8,10-11,17H,5-6,9H2,1-2H3;1-5H,(H,8,9)
• Klucz InChI: JPRXYLQNJJVCMZ-UHFFFAOYSA-N
• informacje o genach: human ... HTR1B(3351) , HTR1D(3352)

Opis

Opis ogólny

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Zastosowanie

Rizatriptan benzoate BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Rizatriptan Tablets

Rizatriptan Orodispersible Tablets

Działania biochem./fizjol.

Rizatriptan is a serotonin 5HT-1B/1D-receptor agonist used to treat migraine.

Opakowanie

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Inne uwagi

Sales restrictions may apply.

Ta strona może zawierać tekst przetłumaczony maszynowo.